Senior Statistician

TN United Kingdom; Greater London; On-site; GBP 125,000 - 150,000; Full time

Job description

The Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU) is recruiting to its statistical team. We want to hear from you if you:

• like the challenge of analysing clinical trial datasets and want to become part of a statistical team that is dedicated to translating cutting-edge science into quality clinical trials that can transform cancer care;
• want variety in your work and opportunities to apply and broaden your statistical knowledge across a number of therapeutic areas in oncology;
• like to work as part of a multi-disciplinary research team with like-minded statisticians, clinical investigators, translational analysts, bioinformaticians, and trial managers.

Applications are now open for a Senior Statistician position to join our team of over 20 statisticians. This post offers an excellent opportunity for an enthusiastic and well-motivated statistician to work in a dynamic and supportive academic environment at one of the leading UK cancer trials units.

Key Requirements

The successful applicant will have a post-graduate qualification in statistics or an allied field (or a first degree in statistics along with practical experience in medical statistics). Additionally, they should demonstrate a solid understanding of clinical trials and experience in applying statistical methods to real-world data. Effective oral and written communication skills and enthusiasm for collaborating with researchers from different disciplines are essential.

Department/Directorate Information

ICR-CTSU manages an exciting portfolio of national and international phase II and III clinical trials and an expanding number of early phase I/II cancer trials. You will work as part of a multi-disciplinary team on the statistical development, oversight and analysis of a number of clinical trials within ICR-CTSU’s portfolio and the ICR/Royal Marsden Drug Development Unit’s early phase trials portfolio as well as on associated trials methodology research and translational biomarker research studies.